Nanoform has filed for a dual listing in Sweden and Finland, marking the first time that a University of Helsinki spinout is seeking an initial public offering.
Nanoform, a Finland-based drug particle engineering spinout of University of Helsinki, yesterday priced its shares at €3.45 ($3.78) and will raise $76.7m when it goes public on June 4.
The spinout will issue approximately 20.3 million shares and will undertake a dual listing on the Nasdaq First North Premier Growth Markets in Sweden and Finland.
Additionally, the co-founders and certain shareholders, including the institution’s endowment Helsinki University Funds, will put up more than 2.3 million shares for sale.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
